Abstract:Thrombotic diseases have been considered major causes of death around the world. Treatments with thrombolytic drugs, such as recombinant tissue-plasminogen activator, urokinase, and streptokinase, are reported to have a life-threatening bleeding tendency. On the contrary, lumbrokinase, identified from Lumbricus rubellus , is specific to fibrin and does not cause excessive bleeding. It possesses fibrinolytic activity and activation of plasminogen to dissolve fibrin. Hence, the purification of fibrinolytic protein monomer from earthworm and antithrombotic evaluation and investigation of mechanisms are needed. In this study, a novel fibrinolytic protein EPF3, with strong fibrinolytic activity, was purified from Pheretima vulgaris by ion exchange and size exclusion chromatography. SDS PAGE, bottom-up proteomics analysis, de novo sequencing, and circular dichroism (CD) analysis were carried out for identification and characterization of it. EPF3, with a molecular weight of 25136.24 Da, consisted of 241 amino acids and contained various forms of secondary structures, including α-helix (3.9%), β-sheet (42.8%), β-turn (21.2%), and random coil (32.1%). It was a trypsin-like serine protease and stable at pH 7.0 to 11.0 and below 40°C. EPF3 was confirmed to possess an antithrombotic effect by ex vivo clot lysis test and fibrinogen-thrombin time (Fib-TT) assay. The three-dimensional structure of EPF3 was predicted by SWISS-MODEL. Molecular docking analysis predicted that EPF3 could directly interact with antithrombotic target proteins (fibrin, fibrinogen, and plasminogen), which was further confirmed by further studies. The antithrombotic mechanism of EPF3 was clarified to be outstanding direct fibrinolysis, fibrinogenolytic activity, and certain activation of plasminogen. EPF3 possesses the potential to be developed into a promising antithrombotic agent.

Pharmacologic Effects and Immunogenicity of Fibrinolytic Enzyme UFEⅠ from Urechis unicinctus

Thrombolytic Effect,Hemolytic Toxiciity and Acute Toxicity of the Fibrinolytic Enzyme UFE-I from Urechis Unicinctus

Antithrombotic effects of a newly purified fibrinolytic protease from Urechis unicinctus.

Purification and Biological Activity of Fibrinolytic Enzyme from Urechis unicinctus

Isolation and Purification of Fibrinolytic Enzyme from Urechis unicinctus and Primary Study of Its Character

Biochemical and enzymatic properties of a novel marine fibrinolytic enzyme from Urechis unicinctus

Enzymatic Properties of UFE,a Novel Marine Fibrinolytic Enzyme

Separation,Purification and Zymological Property of Fibrinolytic Enzyme UFE-Ⅱ from Urechis unicinctus

Molecular Cloning of Urechis unicinctus Fibrinolytic Enzymes Ⅱ

Purification and Characterization of a New Serine Protease with Fibrinolytic Activity from the Marine Invertebrate, Urechis unicinctus

Molecular Cloning of Urechis unicinctus Fibrinolytic Enzymes UFEⅢand Prokaryotic Expression

[Effect of a Novel Fibrinolytic Enzyme FA-I on Thrombosis and Thrombolysis].

Study on the antithrombotic activity of Umbilicaria esculenta polysaccharide.

UFEIII, a Fibrinolytic Protease from the Marine Invertebrate, Urechis Unicinctus.

The effect of fibrinolytic enzyme FIIa from Agkistrodon acutus venom on disseminated intravascular coagulation in rabbits.

A fibrinolytic protease AfeE from Streptomyces sp. CC5, with potent thrombolytic activity in a mouse model

A Novel Fibrinolytic Protein From Pheretima vulgaris: Purification, Identification, Antithrombotic Evaluation, and Mechanisms Investigation

In Vitro Study of the Fibrinolytic Activity Via Single Chain Urokinase-Type Plasminogen Activator and Molecular Docking of FGFC1

STUDIES ON FIBRINOLYTIC FUNCTION OF SUBTILISIN AND ITS MECHANISM

The Effect of the Fibrinolytic Enzyme FIIa from Agkistrodon Acutus Venom on Acute Pulmonary Thromboembolism

Study on Purification and Activity of Earthworm Fibrinolytic Enzyme (efe)with Lower M_r